You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 2, 2025

Drug Price Trends for NDC 69367-0361


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 69367-0361

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

69367-0361 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 69367-0361 (Rosuvastatin Calcium)

Overview of Rosuvastatin Calcium

Rosuvastatin Calcium, identified by the NDC code 69367-0361, is a statin medication manufactured by Westminster Pharmaceuticals, LLC. It is used to lower cholesterol and triglyceride levels in the blood, reducing the risk of cardiovascular disease.

Current Market Trends

Drug Price Inflation

The pharmaceutical industry is experiencing significant price inflation, with Vizient, Inc. projecting a 3.8% increase in drug prices for 2024, driven largely by specialty pharmaceuticals. However, this projection is more relevant to high-cost, complex, or chronic condition treatments rather than generic or statin medications like Rosuvastatin Calcium[2].

Generic and Biosimilar Impact

Generic drugs, including statins like Rosuvastatin, are less likely to see significant price increases compared to specialty medications. In fact, biosimilars and generic drugs are expected to increase in price by only 0.55%, which suggests a relatively stable pricing environment for Rosuvastatin Calcium[2].

Pricing and Access Issues

C-suite executives in the life sciences industry identify pricing and access to drugs as a major issue. However, for generic medications like Rosuvastatin Calcium, the impact is generally less severe compared to specialty drugs. The industry is also seeing a significant impact from the patent cliff, with many high-revenue products losing exclusivity, but this is more relevant to brand-name drugs rather than generics[3].

Global Pricing Comparisons

The average price per unit of drugs in the U.S. is significantly higher than in other regions. For example, prices in the U.S. are 5.5 times those in the OECD (excluding the U.S.) and 7.7 times those in the rest of the world. However, this disparity is more pronounced for brand-name and specialty drugs rather than generics[4].

Regulatory Environment

The FDA's National Drug Code (NDC) Directory ensures that all drugs, including generics like Rosuvastatin Calcium, are properly listed and regulated. This regulatory framework helps maintain consistency and transparency in drug pricing and availability[5].

Market Projections for Rosuvastatin Calcium

Price Stability

Given the nature of Rosuvastatin Calcium as a generic medication, it is likely to experience relatively stable pricing. The minimal projected price increase for generic and biosimilar drugs suggests that the cost of Rosuvastatin Calcium will not rise significantly in the near future[2].

Market Competition

The presence of multiple generic manufacturers, including Westminster Pharmaceuticals, LLC, contributes to a competitive market environment. This competition typically keeps prices in check, as manufacturers strive to remain competitive in the market[1].

Demand and Utilization

The demand for statin medications like Rosuvastatin Calcium remains steady due to their widespread use in managing cholesterol levels. This consistent demand, coupled with the availability of generic options, helps maintain a stable market for these drugs[3].

Key Takeaways

  • Price Stability: Rosuvastatin Calcium is likely to experience minimal price increases due to its generic status.
  • Market Competition: Multiple generic manufacturers ensure a competitive market, keeping prices stable.
  • Regulatory Compliance: The FDA's NDC Directory ensures transparency and consistency in drug pricing and regulation.
  • Global Pricing Disparities: While U.S. drug prices are generally higher, this disparity is more significant for brand-name and specialty drugs.

FAQs

What is the NDC code for Rosuvastatin Calcium manufactured by Westminster Pharmaceuticals, LLC?

The NDC code for Rosuvastatin Calcium manufactured by Westminster Pharmaceuticals, LLC is 69367-0361[1].

What is the projected price increase for generic drugs like Rosuvastatin Calcium in 2024?

The projected price increase for generic drugs, including Rosuvastatin Calcium, is expected to be minimal, with an increase of only 0.55%[2].

How does the FDA regulate generic drugs like Rosuvastatin Calcium?

The FDA regulates generic drugs through the National Drug Code (NDC) Directory, ensuring that all drugs are properly listed and meet regulatory standards[5].

What are the main factors influencing the price of Rosuvastatin Calcium?

The main factors include market competition among generic manufacturers, regulatory compliance, and the overall demand for statin medications[1][2][3].

How does the global pricing disparity affect the cost of Rosuvastatin Calcium in the U.S.?

While the U.S. has significantly higher drug prices compared to other regions, this disparity is more pronounced for brand-name and specialty drugs rather than generics like Rosuvastatin Calcium[4].

Sources

  1. FindACode: Westminster Pharmaceuticals, LLC - List of Drugs - NDC Labeler.
  2. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  3. Deloitte Insights: 2025 life sciences outlook.
  4. ASPE: ISSUE BRIEF - International Market Size and Prices.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.